Petrovax Pharm launches inaugural nationwide TV media campaign for Longidaze®

Petrovax Pharm has launched a federal TV media campaign advertising Longidaze®, an innovative medication delivering sophisticated urological and gynecological benefits. The media campaign targets patients experiencing problems with prostatitis.

In November 2018, Longidaze® won out in the category of ‘Medication of Choice for the pathogenetic treatment of chronic prostatitis and relapse prevention’ at the Russian Pharma Awards. This award represents well-deserved recognition of the product’s efficacy as a chronic prostatitis treatment due to its unique formula, mechanism of action, and high quality. Petrovax Pharm continues to promote innovatative, highly effective medications for wide use.

More about Longidaza® on website

[1] Prindex_Comcon, осень 2017г., Proxima Pharma_RX Test Russia, 2017

[2] Количество назначений препарата Лонгидаза® врачами (10 специальностей) за 2017 год. Данные Proxima Pharma_RX Test Russia

Previous news

Russian Health Week: Petrovax Pharm participates in PharmMedProm-2018 Exhibition and Russia’s Immunobiological Shield Congress